We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Demonstrates Whole Blood Critical and POC Testing Solutions at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Stat Profile Prime Plus  (Photo courtesy of Nova Biomedical)
Image: Stat Profile Prime Plus (Photo courtesy of Nova Biomedical)

Nova Biomedical (Waltham, MA, USA) demonstrated its whole blood critical and POC testing solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo held at the Georgia World Congress Center in Atlanta, September 26-30.

The event provided an unparalleled opportunity to connect with global leaders in laboratory medicine, and to discover cutting edge technology & vital research in the field.

Nova is a world leader in whole blood critical and POC testing, offering hospital meters (including StatStrip Glucose, the only FDA-cleared meter for critically ill testing) and Stat Profile Prime critical care blood gas analyzers. At AACC 2021, Nova demonstrated its Stat Profile Prime Plus - a comprehensive, whole blood critical care analyzer that offers blood gases, electrolytes, metabolites, hematology, and co-oximetry, in a simple, compact device. Prime Plus combines maintenance-free, replaceable cartridge technology for sensors and reagents with patented, maintenance-free, and non-lysing whole blood co-oximetry technology. The analyzer uses a small 135µL sample, produces a complete 22-test panel in about one minute, and offers automated quality control with real-time, supplement quality monitoring of each sample analysis, calibration, and QC analysis. Prime Plus is the only critical care analyzer that includes BUN, creatinine, ionized magnesium, estimated plasma volume, and MCHC in its test menu. The complete test menu includes pH, PCO2, PO2, Na, K, Cl, iCa, iMg, Glucose, Lactate, BUN/Urea, Creatinine, Hct, Hb, estimated Plasma Volume, MCHC, SO2%, and CO-Oximetry.

At AACC 2021, Nova also displayed the StatStrip Glucose Hospital Meter, which is the only glucose meter cleared by the FDA for use with critically ill patients and CLIA-waived for use with ALL patients and ALL sample types. StatStrip Glucose has no known interferences and brings lab-like accuracy to bedside glucose testing - accuracy validated in an FDA submission study of 1,698 critically ill patients with 257 different and specific medical conditions, and over 8,000 medications, as well as over 200 published studies worldwide. StatStrip Glucose measures glucose and corrects for hematocrit, maltose, and other interferences that can cause erroneous results on other meters.

Related Links:
Nova Biomedical 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.